Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.

David Virós PorcunaC Pollan GuisasolaC Viña SoriaB Cirauqui CirauquiL Pardo MuñozF ColluráR Mesia Nin

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)

TORS is a safe and effective treatment for HPV-negative T1-2 OPSCC patients. The positive margin rate was worse in T3-4 patients, indicating the need for careful patient selection in this subgroup.

Keyphrases

end stage renal disease
squamous cell carcinoma
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
case report
patient reported outcomes
patient reported
study protocol
smoking cessation